Literature DB >> 24021424

Transcription factor NRF2 protects mice against dietary iron-induced liver injury by preventing hepatocytic cell death.

Sandro Silva-Gomes1, Ana G Santos1, Carolina Caldas1, Cátia M Silva2, João V Neves1, Joanne Lopes3, Fátima Carneiro4, Pedro N Rodrigues5, Tiago L Duarte6.   

Abstract

BACKGROUND & AIMS: The liver, being the major site of iron storage, is particularly exposed to the toxic effects of iron. Transcription factor NRF2 is critical for protecting the liver against disease by activating the transcription of genes encoding detoxification/antioxidant enzymes. We aimed to determine if the NRF2 pathway plays a significant role in the protection against hepatic iron overload.
METHODS: Wild-type and Nrf2(-/-) mouse primary hepatocytes were incubated with ferric ammonium citrate. Wild-type and Nrf2(-/-) mice were fed standard rodent chow or iron-rich diet for 2weeks, with or without daily injection of the antioxidant mito-TEMPOL.
RESULTS: In mouse hepatocytes, iron induced the nuclear translocation of NRF2 and the expression of cytoprotective genes in an NRF2-dependent manner. Moreover, Nrf2(-/-) hepatocytes were highly susceptible to iron-induced cell death. Wild-type and Nrf2(-/-) mice fed iron-rich diet accumulated similar amounts of iron in the liver and were equally able to increase the expression of hepatic hepcidin and ferritin. Nevertheless, in Nrf2-null mice the iron loading resulted in progressive liver injury, ranging from mild confluent necrosis to severe necroinflammatory lesions. Hepatocytic cell death was associated with gross ultrastructural damage to the mitochondria. Notably, liver injury was prevented in iron-fed animals that received mito-TEMPOL.
CONCLUSIONS: NRF2 protects the mouse liver against the toxicity of dietary iron overload by preventing hepatocytic cell death. We identify NRF2 as a potential modifier of liver disease in iron overload pathology and show the beneficial effect of the antioxidant mito-TEMPOL in a mouse model of dietary iron-induced liver injury.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  8-Hydroxy-2′-deoxyguanosine; 8-OHdG; 8-hydroxy-2′-deoxyguanosine; AC; ALT; ARE; AST; Antioxidant; FAC; HH; Hemochromatosis; Hepatocyte; MPT; Mito-TEMPOL; Necrosis; PI; RER; ROS; SER; alanine aminotransferase; ammonium citrate; antioxidant response element; aspartate aminotransferase; ferric ammonium citrate; hOGG1; hereditary hemochromatosis; human 8-hydroxyguanine DNA glycosylase 1; mitochondrial permeability transition; propidium iodide; reactive oxygen species; rough endoplasmic reticulum; smooth endoplasmic reticulum

Mesh:

Substances:

Year:  2013        PMID: 24021424     DOI: 10.1016/j.jhep.2013.09.004

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  21 in total

Review 1.  p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.

Authors:  Koji Taniguchi; Shinichiro Yamachika; Feng He; Michael Karin
Journal:  FEBS Lett       Date:  2016-08-06       Impact factor: 4.124

2.  Activation of NRF2 Signaling in HEK293 Cells by a First-in-Class Direct KEAP1-NRF2 Inhibitor.

Authors:  Xia Wen; Gabriell Thorne; Longqin Hu; Melanie S Joy; Lauren M Aleksunes
Journal:  J Biochem Mol Toxicol       Date:  2015-02-12       Impact factor: 3.642

Review 3.  Physiology and pathophysiology of iron in hemoglobin-associated diseases.

Authors:  Thomas D Coates
Journal:  Free Radic Biol Med       Date:  2014-04-12       Impact factor: 7.376

Review 4.  The role of iron and reactive oxygen species in cell death.

Authors:  Scott J Dixon; Brent R Stockwell
Journal:  Nat Chem Biol       Date:  2014-01       Impact factor: 15.040

5.  Experimental evidence for the therapeutic potential of tempol in the treatment of acute liver injury.

Authors:  Mekky M Abouzied; Heba M Eltahir; Ashraf Taye; Mahran S Abdelrahman
Journal:  Mol Cell Biochem       Date:  2015-10-06       Impact factor: 3.396

6.  Nrf2 controls iron homeostasis in haemochromatosis and thalassaemia via Bmp6 and hepcidin.

Authors:  Pei Jin Lim; Tiago L Duarte; João Arezes; Daniel Garcia-Santos; Amel Hamdi; Sant-Rayn Pasricha; Andrew E Armitage; Hema Mehta; Sarah Wideman; Ana G Santos; Andreia Santos-Gonçalves; Alireza Morovat; Jim R Hughes; Elizabeth Soilleux; Chia-Yu Wang; Abraham L Bayer; Paul Klenerman; Christian B Willberg; Richard C Hartley; Michael P Murphy; Jodie L Babitt; Prem Ponka; Graça Porto; Hal Drakesmith
Journal:  Nat Metab       Date:  2019-05-13

7.  Increased intracellular iron in mouse primary hepatocytes in vitro causes activation of the Akt pathway but decreases its response to insulin.

Authors:  Joe Varghese; Jithu James; Sophie Vaulont; Andrew Mckie; Molly Jacob
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-05-31       Impact factor: 3.770

8.  Coordination of iron homeostasis by bone morphogenetic proteins: Current understanding and unanswered questions.

Authors:  Allison L Fisher; Jodie L Babitt
Journal:  Dev Dyn       Date:  2021-05-25       Impact factor: 3.780

Review 9.  The Role of Iron in Benign and Malignant Hematopoiesis.

Authors:  Sayantani Sinha; Joana Pereira-Reis; Amaliris Guerra; Stefano Rivella; Delfim Duarte
Journal:  Antioxid Redox Signal       Date:  2021-01-07       Impact factor: 7.468

Review 10.  The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism.

Authors:  Sílvia S Chambel; Andreia Santos-Gonçalves; Tiago L Duarte
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.